Zhuang Z, Roth M J, Emmert-Buck M R, Lubensky I A, Liotta L A, Solomon D
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1500.
Acta Cytol. 1994 Sep-Oct;38(5):671-5.
Previous studies have demonstrated von Hippel-Lindau (VHL) gene abnormalities in renal cell carcinoma. Archival cytologic samples of renal cell carcinomas (RCCs) from two patients were evaluated for allelic loss of the VHL gene. Small clusters of renal carcinoma cells were dissected from cytocentrifuge preparations under direct microscopic visualization followed by single-step DNA extraction and subsequent polymerase chain reaction (PCR). Amplification of DNA from the harvested tumor cells demonstrated a loss of heterozygosity at the VHL gene in five RCC specimens obtained from two patients. The combination of microdissection and PCR enabled DNA studies to be performed on a pure population of tumor cells isolated from heterogeneous samples containing admixed normal cellular elements. Selected genetic studies performed on microscopically targeted cells will help to further the biologic and cytomorphologic characterization of the targeted cell population.
先前的研究已证实肾细胞癌中存在冯·希佩尔-林道(VHL)基因异常。对两名患者肾细胞癌(RCC)的存档细胞学样本进行了VHL基因的等位基因缺失评估。在直接显微镜观察下,从细胞离心涂片制备物中分离出小簇肾癌细胞,随后进行单步DNA提取及后续聚合酶链反应(PCR)。对采集的肿瘤细胞进行DNA扩增,结果显示从两名患者获取的5个RCC标本中VHL基因存在杂合性缺失。显微切割与PCR相结合,使得能够对从含有混合正常细胞成分的异质样本中分离出的纯肿瘤细胞群体进行DNA研究。对经显微镜靶向的细胞进行特定的基因研究,将有助于进一步明确靶向细胞群体的生物学和细胞形态学特征。